Senior Correspondent, London
Ben's Feed
Aug 20, 2014

Experimental Ebola drugs needed for ‘up to 30,000 people’

LONDON (Reuters) – Up to 30,000 people could have used experimental treatments or vaccines so far in the world’s worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday.

The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of unproven drugs that are likely to be available in the near term to fight the deadly disease.

Aug 20, 2014
Aug 19, 2014
Aug 19, 2014

U.S. clears AstraZeneca over heart drug trial

LONDON (Reuters) – The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects.

The drugmaker said on Tuesday the Department of Justice (DoJ) was closing the probe into the 18,000-patient study and no further action was planned.

Aug 17, 2014
Aug 17, 2014

Insight – Extreme medicine: The search for new antibiotics

NORWICH England (Reuters) – Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it’s well worth trying.

    As the world cries out for new antibiotics, researchers at the John Innes Centre (JIC) in Norwich are also taking a bet on bacteria extracted from the stomachs of giant stick insects and cinnabar caterpillars with a taste for highly toxic plants.

Aug 17, 2014

Extreme medicine: The search for new antibiotics

NORWICH, England, Aug 17 (Reuters) – Pampering leafcutter
ants with fragrant rose petals and fresh oranges may seem an
unlikely way to rescue modern medicine, but scientists at a lab
in eastern England think it’s well worth trying.

As the world cries out for new antibiotics, researchers at
the John Innes Centre (JIC) in Norwich are also taking a bet on
bacteria extracted from the stomachs of giant stick insects and
cinnabar caterpillars with a taste for highly toxic plants.

Aug 15, 2014
Aug 15, 2014
Aug 15, 2014
    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."
    • More from Ben

    • Follow Ben